Botulinum Toxin in Cosmetic Practice
On this page
Direct answer
Twenty units, five injection points, one frowning forehead: that is the classical glabellar regimen of onabotulinumtoxinA — the anchor number of cosmetic botulinum therapy, flanked by 10-20 units for the frontalis and 24 units for the crow's feet (12 per side). The toxin's serotype A molecules cleave SNAP-25, one of the SNARE proteins docking acetylcholine vesicles at the neuromuscular junction, producing chemodenervation that appears over two to three days, peaks near two weeks and fades over three to four months as terminals resprout. Units are not interchangeable between brands — the practical reason prescriptions name the product. Absolute contraindications are myasthenia gravis and Lambert-Eaton syndrome, aminoglycoside co-therapy and infection at the injection site; pregnancy and lactation are avoided as a matter of policy rather than proven harm.
What you must remember
- Dose map by region: glabella 20 units in five points (procerus, both corrugators, medial frontalis); frontalis 10-20 units; lateral canthus 24 units total; masseter 25-50 units per side for square-face reshaping and bruxism — the Asian-practice favourite.
- Beyond the classic three: bunny lines, gummy smile (levator labii superioris alaeque nasi), depressor anguli oris, mentalis, platysmal bands and the "Nefertiti lift"; axillary hyperhidrosis 50-100 units per side after iodine-starch mapping.
- Pharmacology link: type A toxin cleaves SNAP-25; type B cleaves VAMP/synaptobrevin — the crossover fact that ties cosmetic dermatology back to physiology and food-borne botulism.
- Kinetics: onset at 24-72 hours, peak effect around 7-14 days, functional return by 3-4 months; re-treatment waits at least twelve weeks to limit antibody-mediated secondary non-response.
- The two classic complications: brow ptosis from over-treating the frontalis, and eyelid ptosis from glabellar diffusion into the levator palpebrae superioris — the latter rescued by apraclonidine 0.5 per cent or phenylephrine drops stimulating Muller's muscle.
- Contraindication list verbatim: myasthenia gravis, Lambert-Eaton myasthenic syndrome, aminoglycosides and other agents impairing neuromuscular transmission, active infection at the site; avoid in pregnancy and lactation.
- Technique notes: reconstitution with preserved saline reduces injection sting; aspiration is unnecessary in the cosmetic planes; keep away from the orbital rim unless deliberately treating the lateral canthus.
- Indian practice: botulinum toxin A 100-unit vials from several manufacturers are available locally at a fraction of originator cost, fuelling both wider access and the problem of unqualified injection — a medico-legal viva theme in itself.
A first-time cosmetic consult, worked through
A 29-year-old dance instructor wants her "angry face" softened before her wedding season, with no medical history and no prior cosmetic procedures. After photography and dynamic assessment, the plan is glabella 20 units in five points and frontalis 10 units in a V-pattern low on the forehead, preserving brow position and lateral eyebrow lift. She is counselled with precision: results appear over the next three days, peak at two weeks, last about three to four months, and the first expression change feels "heavy" for a fortnight. Ice and topical anaesthesia suffice; the procedure takes ten minutes. At two-week review, a 1 mm right brow asymmetry is noted and corrected with a balancing 2 units into the left frontalis — the touch-up visit every good practice schedules as routine. Her return at four months marks the natural re-treatment interval; spacing visits beyond twelve weeks, avoiding stacking of high doses, and documenting units per site protect both her face and the practitioner's record against secondary non-response and medico-legal noise.
Where candidates slip
The unit map is where marks are won and lost: candidates who quote "50 units to the forehead" reveal guesswork — frontalis is 10-20 units precisely because overtreatment drops the brow. The second slip is mechanism vagueness: saying the toxin "blocks nerves" earns nothing; naming SNAP-25 cleavage and failed vesicle fusion earns everything, and links beautifully to tetanus (VAMP cleavage centrally) and to the physiology of the neuromuscular junction. Third, the ptosis pair: brow ptosis (frontalis over-dosed) versus eyelid ptosis (glabellar diffusion to levator palpebrae superioris), with apraclonidine drops as the specific rescue — a favourite "what next" question. Finally, brand arithmetic: units of different preparations are not interchangeable, and the abobotulinum-to-onabotulinum conversion is famously imprecise — saying so precisely is safer than quoting a fixed ratio.
Frequently asked questions
What is the standard onabotulinumtoxinA regimen for the glabellar complex?
20 units divided across five injection points covering procerus, both corrugator supercilii and medial frontalis fibres.
How does botulinum toxin type A produce its effect?
It cleaves SNAP-25, preventing SNARE-mediated acetylcholine vesicle fusion at the neuromuscular junction and causing reversible chemodenervation.
How is iatrogenic eyelid ptosis after glabellar injection managed?
Apraclonidine 0.5 per cent or phenylephrine eyedrops stimulate Muller's muscle as a temporary lift while the diffusion effect wears off over weeks.
Which conditions absolutely contraindicate cosmetic botulinum toxin?
Myasthenia gravis and Lambert-Eaton syndrome, co-administration of aminoglycosides or other neuromuscular-blocking agents, and infection at the injection site.
Why space re-treatment intervals at twelve weeks or more?
Frequent high-dose exposure risks neutralising antibody formation and secondary treatment failure, beyond simply wasting product.